MetPath Review Center

Enriching the minds of laboratory scientists worldwide

About Us

MetPath Review Center started in 1999, with its first office at Durian Hotel, then in Davao Medical School Foundation along JP Laurel Ave., Davao City, Philippines. MetPath was founded by Howard Denila, the author of the famous Hematology for Medical Laboratory Science Examination Review Notes, with the helped of his co-professors in Davao's finest colleges and universities - San Pedro College, Universitiy of Immaculate Conception and Davao Medical School Foundation, MetPath came into a reality. The first and only accredited medtech review center in Davao City and throughout Mindanao.

The mission and vision laid out by Denila, remains MetPath's mission and vision today, summed up in a simple but powerful words: "To re-educate graduates of medical technology/medical laboratory science."

MetPath is dedicated to advancing both students' knowledge and skills while passing the licensure examination.  Denila believed that success in one depends on the success of the other. A licensed medical laboratory scientist, he believed, must do both well.

After more than 15 years now, MetPath boast of its most powerful, complete, and updated Review Notes synthesized from the latest reference books available for medical laboratory science, worldwide. This exclusive MetPath Review Notes was written in an easy logical approach of learning each subjects compared to the often lengthy and confusing textbooks in bookstores. 

MetPath's has already served thousands of Filipino and Foreign medical technology graduates, not only in the Philippines but also in the USA, Canada, Japan, Abu-Dhabi, Australia, Europe and the Middle East through MetPath's Online Review Program.

The review program is focused on medical laboratory science licensure exam, such as, the Philippine Medical Laboratory Science, American Society for Clinical Pathology (ASCP), American Medical Technologists (AMT), Health Authority-Abu Dhabi (HA-AD), Canadian Society for Medical Laboratory Science (CSMLS). and Australian Institute of Medical Scientists (AIMS).

To GOD be the Glory! 

<updated October 2016>


Shulamitte Faith Faburada, MLS(ASCP)
Janine Anne Juyo, MLS(ASCP)
Margarette Denila, MLS(ASCP)
Reymond Lim, MLS(ASCP)
Johanna Maree Crave, MLS(ASCP)
Eanne Jairah Reyes, MLS(ASCP)
Stella Ramirez, MLS(ASCP)
Lee Marco Mutia, MLS(ASCP)
Mary Clare Cesar, MLS(ASCP)
Mariam Louise Nisal, MLS(ASCP)

Main Center

104 Jaltan Bldg.
CM Recto cor Bonifacio Street,
Davao City 8000, PHL         

DTI Cert. No. 00147471

Share MetPath to a friend

Recent Diagnostic Posts

Safety Tests Of Ebola Vaccines To Start This Fall.


The AP (Perrone, Neergaard) reports that safety trials are to begin for two experimental Ebola vaccines. Safety tests “typically are performed on a few dozen to 100 people.” The first, “developed by researchers at the National Institutes of Health” and GlaxoSmithKline should be tested in the next few months and is “based on a chimpanzee adenovirus.” Dr. Anthony Fauci has explained that it is “purely preventive, more aimed at giving it to the health care workers who put themselves at considerable danger.” The second, developed by researchers at the Canadian national laboratory and NewLink Genetics of Ames, Iowa, is expected to be tested “in up to 100 health volunteers with the FDA” though the timetable has not been set. The NIH is also supporting development of “at least two other candidate Ebola vaccines,” the first from Crucell, which “could begin human testing by late 2015,” and the second from Profectus Biosciences.